Young Mitochondria Transferred Between Ovarian Cells Reverse Reproductive Aging

Female reproductive aging is characterized by declining oocyte quality, reduced ATP output in follicular somatic cells, and progressive loss of intercellular communication. While mitochondrial dysfunction is recognized as central to this process, most therapeutic approaches involve invasive mitochondrial transplantation or systemic metabolic supplements. This study asked whether the ovary's own cells could be coaxed into sharing mitochondria more effectively to restore bioenergetic function.

Researchers used human primary cumulus cells (CCs) and the HGL5 granulosa cell line to model young versus aged ovarian somatic cells. Using dual MitoTracker labeling, co-culture systems, and label-free 3D live imaging, they demonstrated that young granulosa cells (yGCs) spontaneously transfer mitochondria to aged granulosa cells (aGCs) through tunneling nanotubes (TNTs)—F-actin-rich cytoplasmic bridges. This transfer was contact-dependent: conditioned medium from young cells did not replicate the effect, ruling out paracrine signaling. Critically, mitochondrial transfer declined significantly with cell age, correlating with reduced TNT formation.

Mitochondrial receipt by aged cells produced functional improvements measurable by Seahorse bioenergetics: basal and maximal oxygen consumption rates increased, ATP-linked respiration rose, and spare respiratory capacity improved. Recipient cells shifted from glycolytic to oxidative ATP production, mitochondrial morphology became more tubular and fusion-competent, and markers of oxidative stress (DCFDA, MitoSOX) declined. Western blots confirmed upregulation of fusion proteins and reduced DRP1 phosphorylation, consistent with healthier mitochondrial dynamics.

Two approaches were tested to enhance TNT-mediated mitochondrial transfer. FTY720, a sphingosine-1-phosphate receptor modulator with known cytoskeletal effects, significantly increased TNT formation and mitochondrial delivery to aged cells in vitro. Separately, embedding granulosa cells in soft (physiologically relevant stiffness) 3D ECM hydrogels promoted spheroid formation, activated YAP mechanosensing signaling, and restored mitochondrial function without pharmacological agents—suggesting that physical microenvironmental cues alone are sufficient to reactivate intercellular mitochondrial cooperation. Transcriptomic analysis supported broad bioenergetic and structural remodeling under both conditions.

In vivo validation in aged female mice (>30 weeks) treated with FTY720 (2 mg/kg/week, i.p., 8 weeks) showed increased antral and primordial follicle counts, improved oocyte mitochondrial quality, higher polar body extrusion rates, and elevated serum AMH levels compared to untreated aged controls. Immunostaining confirmed increased Miro1 expression, a mitochondrial trafficking protein, in treated ovarian tissue. Together, these findings establish that somatic cell contact and cytoskeletal integrity are essential gatekeepers of mitochondrial complementation in the aging ovary, and that both can be therapeutically targeted.